Myeloid Progenitor Cell Proliferation and Mobilization Effects of BB10010, a Genetically Engineered Variant of Human Macrophage Inflammatory Protein-1, in a Phase I Clinical Trial in Patients with Relapsed/Refractory Breast Cancer

Author： Broxmeyer H.E.   Orazi A.   Hague N.L.   Sledge G.W.   Rasmussen H.   Beutler M.E.S.  

Publisher： Academic Press

ISSN： 1079-9796

Source： Blood Cells, Molecules, and Diseases, Vol.24, Iss.1, 1998-03, pp. : 14-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protective effects of BB-10010 treatment on chemotherapy-induced neutropenia in mice - an active variant of human macrophage inflammatory protein-1a with improved pharmaceutical properties

By Gilmore G.L.   DePasquale D.K.   Shadduck R.K.  

Experimental Hematology, Vol. 27, Iss. 2, 1999-02 ,pp. : 195-202

Elsevier

Access to resources Recommend Favorite

Antibody Response to DT–GM, a Novel Fusion Toxin Consisting of a Truncated Diphtheria Toxin (DT) Linked to Human Granulocyte–Macrophage Colony Stimulating Factor (GM), during a Phase I Trial of Patients with Relapsed or Refractory Acute Myeloid Leukemia

By Hall P.D.   Virella G.   Willoughby T.   Atchley D.H.   Kreitman R.J.   Frankel A.E.  

Clinical Immunology, Vol. 100, Iss. 2, 2001-08 ,pp. : 191-197

Academic Press

Access to resources Recommend Favorite

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer - investigation of dose level with clinical correlates

By Burns L.J.   Weisdorf D.J.   DeFor T.E.   Repka T.L.   Ogle K.M.   Hummer C.   Miller J.S.  

Experimental Hematology, Vol. 28, Iss. 1, 2000-01 ,pp. : 96-103

Elsevier

Access to resources Recommend Favorite

A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

By Ogawa Yoshiaki   Ogura Michinori   Suzuki Tatsuya   Ando Kiyoshi   Uchida Toshiki   Shirasugi Yukari   Tobinai Kensei   Lee Je   Kase Masazumi   Katsura Koichi   Hotta Tomomitsu  

International Journal of Hematology, Vol. 98, Iss. 2, 2013-08 ,pp. : 164-170

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: A phase I/II study of ofatumumab (GSK1841157) in Japanese and Korean patients with relapsed or refractory B-cell chronic lymphocytic leukemia

By Ogawa Yoshiaki   Ogura Michinori   Suzuki Tatsuya   Ando Kiyoshi   Uchida Toshiki   Shirasugi Yukari   Tobinai Kensei   Lee Je   Kase Masazumi   Katsura Koichi   Hotta Tomomitsu  

International Journal of Hematology, Vol. 99, Iss. 3, 2014-03 ,pp. : 354-355

Springer Publishing Company

Access to resources Recommend Favorite